^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

CD19/CD22 chimeric antigen receptor T cell

i
Other names: CD19/CD22 chimeric antigen receptor T cell
Associations
Company:
Kecellitics Biotech
Drug class:
CD19-targeted CAR-T immunotherapy, CD22-targeted CAR-T immunotherapy
Related drugs:
Associations